Partnering and collaborations

IDP Pharma welcomes partnering opportunities to move forward its current programs and to explore the application of IDP Plarma’s technology to the discovery and development of first-in-class drugs modulating the activity of intrinsically disordered, disease driver transcription factors.

IDP Pharma has developed a whole new concept that allows to inhibit intrinsically disordered proteins in general, and disordered transcription factors in particular, by retaining proteins in a disorder, inactive state.

For partnering inquiries, please contact s (dot) esteban (at) idp (hyphen) pharma (dot) com.